RNA Clinical Trials Solutions
-
Orphan And Rare Disease CRO Services
11/7/2023
Rare disease clinical studies demand a specialized full-service CRO with expertise in enrollment, site selection, and global regulatory knowledge for accelerated recruitment.
-
New Next-Generation GMP Facility
5/16/2023
A new state-of-the-art GMP facility has been created to accelerate the development of CRISPR-based cell and gene therapies, overcoming challenges such as procuring reliable GMP-grade sgRNA persist.
-
Early Phase Trials In Australia
9/6/2024
Australia is a preferred destination for early phase trials because of simple and fast regulatory stream and lucrative R&D cash refund scheme.
-
Pharmacometric Services
6/27/2023
Our talented and experienced team can assist in all Clinical Study Phases (Phase 0, I, II and III) and in study designs ranging from First in Human (FIH), Single Ascending Dose (SAD), Multiple Ascending Dose (MAD), Drug-Drug Interaction (DDI), Bioavailability/Bioequivalence (BA/BE), Food Effect as well as Special Population studies.
-
The Importance Of Patient Recruitment In Clinical Trials
3/28/2025
Why Patient Recruitment Matters in Clinical Research
Patient recruitment is one of the most critical aspects of a clinical trial’s success. Without an adequate and diverse participant pool, trials risk failing to generate reliable and representative data. Ensuring sufficient participation is essential for producing statistically valid results that confirm the treatment's safety and effectiveness.
For biotech companies, especially those under tight timelines and budgets, partnering with an experienced CRO like Novotech ensures that patient recruitment efforts are both efficient and effective, enabling timely trial completion and robust data collection.
-
Recruit Patients Faster In The Asia-Pacific Region
9/29/2022
Novotech relies on years of experience, in-country knowledge and real-life big data to identify and propose the best-performing sites and investigators for your study.
-
Novotech Drug Development Consulting: Services For Success
6/27/2023
Delve into the details of this full-service global product development and strategic regulatory group that has a proven track record of successful FDA meetings and approvals.
-
Clinical And Regulatory Strategy
11/7/2023
Many biotechnology companies come to Australia to conduct early phase clinical trials and take advantage of straightforward regulatory streams and of the lucrative 43.5% R&D cash refund scheme. Biotechnology companies then often look at locations in Asia, such as South Korea, Thailand and China to tap into their huge treatment-naïve patient populations for their later phase clinical research.
-
Oncology CRO Services
11/7/2023
Biotechnology companies are facing increased challenges around participant recruitment and retention, lengthy timeframes and relatively high costs.
-
Oncology CRO Services
6/27/2023
Biotechnology companies are facing increased challenges around participant recruitment and retention, lengthy timeframes, and relatively high costs.